The Nigeria Centre for Disease Control (NCDC) has stated Dexamethsaone has not been validated for use in the treatment of COVID-19 patients.

The drug, which scientists in the United Kingdom have hailed as a major breakthrough, is a widely used low-dose steroids, found to considerably reduce the risk of dying from COVID-19.

According to preliminary results by researchers from Oxford University, the drug when administered to more than 2,000 severely ill COVID-19 patients, reduced deaths by 35 percent among those who could only breathe with the help of a ventilator and by one-fifth in other patients receiving oxygen only.

It had no direct benefit to COVID-19 patients who did not require the use of a respirator.

The NCDC, in a statement in Abuja, said: “The Nigeria Centre for Disease Control (NCDC) is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19.

“The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.

“Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19. In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by WHO.

“We are aware of ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone.

‘We will inform the general public on outcomes following scientific review and validation.”

The drug is already being used to reduce inflammation in a range of other conditions, including arthritis, asthma and some skin conditions.

Follow Our WhatsApp Channel ______________________________________________________________________________________________________

[A MUST HAVE] Evidence Act Demystified With Recent And Contemporary Cases And Materials

“Evidence Act: Complete Annotation” by renowned legal experts Sanni & Etti.

Available now for NGN 40,000 at ASC Publications, 10, Boyle Street, Onikan, Lagos. Beside High Court, TBS. Email publications@ayindesanni.com or WhatsApp +2347056667384. Purchase Link: https://paystack.com/buy/evidence-act-complete-annotation

______________________________________________________________________ “Enhance Legal Practice With Authoritative Reports” — Alexander Payne Offers Comprehensive Law Reports, Spanning Over A Century Of Nigerian Jurisprudence

Interested buyers are encouraged to place their orders and enquiries via: 0704 444 4777, 0704 444 4999, 0818 199 9888 Website: www.alexandernigeria.com

______________________________________________________________________